|
1
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hildesheim A and Wang SS: Host and viral
genetics and risk of cervical cancer: A review. Virus Res.
89:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bosch FX and de Sanjosé S: Chapter 1:
Human papillomavirus and cervical cancer - burden and assessment of
causality. J Natl Cancer Inst Monogr. 2003:3–13. 2003. View Article : Google Scholar
|
|
4
|
Smith JS, Lindsay L, Hoots B, Keys J,
Franceschi S, Winer R and Clifford GM: Human papillomavirus type
distribution in invasive cervical cancer and high-grade cervical
lesions: A meta-analysis update. Int J Cancer. 121:621–632. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao S, Yao D, Chen J and Ding N:
Circulating miRNA-20a and miRNA-203 for screening lymph node
metastasis in early stage cervical cancer. Genet Test Mol
Biomarkers. 17:631–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q,
Yang W, Zheng X, Tu K and Liu Q: miR-187-3p inhibits the metastasis
and epithelial-mesenchymal transition of hepatocellular carcinoma
by targeting S100A4. Cancer Lett. 381:380–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mulrane L, Madden SF, Brennan DJ, Gremel
G, McGee SF, McNally S, Martin F, Crown JP, Jirström K, Higgins DG,
et al: miR-187 is an independent prognostic factor in breast cancer
and confers increased invasive potential in vitro. Clin Cancer Res.
18:6702–6713. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chao A, Lin CY, Lee YS, Tsai CL, Wei PC,
Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, et al: Regulation of
ovarian cancer progression by microRNA-187 through targeting
Disabled homolog-2. Oncogene. 31:764–775. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Casanova-Salas I, Masiá E, Armiñán A,
Calatrava A, Mancarella C, Rubio-Briones J, Scotlandi K, Vicent MJ
and López-Guerrero JA: MiR-187 targets the androgen-regulated gene
ALDH1A3 in prostate cancer. PLoS One. 10:e01255762015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F
and Li D: MicroRNA-187-3p mitigates non-small cell lung cancer
(NSCLC) development through down-regulation of BCL6. Biochem
Biophys Res Commun. 471:82–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang F, Luo Y, Shao Z, Xu L, Liu X, Niu
Y, Shi J, Sun X, Liu Y, Ding Y, et al: MicroRNA-187, a downstream
effector of TGFβ pathway, suppresses Smad-mediated
epithelial-mesenchymal transition in colorectal cancer. Cancer
Lett. 373:203–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang ZS, Zhong M, Bian YH, Mu YF, Qin SL,
Yu MH and Qin J: MicroRNA-187 inhibits tumor growth and invasion by
directly targeting CD276 in colorectal cancer. Oncotarget.
7:44266–44276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hampton T: MicroRNA and metastasis. JAMA.
298:1998. 2007. View Article : Google Scholar
|
|
20
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hendrix ND, Wu R, Kuick R, Schwartz DR,
Fearon ER and Cho KR: Fibroblast growth factor 9 has oncogenic
activity and is a downstream target of Wnt signaling in ovarian
endometrioid adenocarcinomas. Cancer Res. 66:1354–1362. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
White AC, Xu J, Yin Y, Smith C, Schmid G
and Ornitz DM: FGF9 and SHH signaling coordinate lung growth and
development through regulation of distinct mesenchymal domains.
Development. 133:1507–1517. 2006. View Article : Google Scholar : PubMed/NCBI
|
